Impact of 18F-Choline PET/CT in the Decision-Making Strategy of Treatment Volumes in Definitive Prostate Cancer Volumetric Modulated Radiation Therapy-Reference-Cited by-同舟云学术

Impact of 18F-Choline PET/CT in the Decision-Making Strategy of Treatment Volumes in Definitive Prostate Cancer Volumetric Modulated Radiation Therapy

Published:2015-11 Issue:11 Volume:40 Page:e496-e500
ISSN:0363-9762
Container-title:Clinical Nuclear Medicine
language:en
Short-container-title:

Author:

Alongi Filippo,Fersino Sergio,Giaj Levra Niccolò,Mazzola Rosario,Ricchetti Francesco,Fiorentino Alba,Ruggieri Ruggero,Malfatti Veronica,Cavalleri Stefano,Salgarello Matteo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference23 articles.

1. Cancer statistics.;Jemal;CA Cancer J Clin,2008

2. Dual-modality imaging: combining anatomy and function.;Townsend;J Nucl Med,2008

3. Use of MRI and spectroscopy in evaluation of external beam radiotherapy for prostate cancer.;Pickett;Int J Radiat Oncol Biol Phys,2004

4. Choline PETCT for prostate cancer: Main clinical applications.;Fuccio;Eur J Radiol,2011

5. Inaugural article: positron emission tomography provides molecular imaging of biological processes.;Phelps;Proc Natl Acad Sci USA,2000

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive value of volumetric parameters based on 18F-PSMA-1007 PET/CT for prostate cancer metastasis;Frontiers in Oncology;2024-02-26

2. PSMA-PET/CT-Based Stereotactic Body Radiotherapy (SBRT) in the Treatment of Uncomplicated Non-Spinal Bone Oligometastases from Prostate Cancer;Cancers;2023-05-17

3. The 18F-PSMA-1007 PET/CT performance on metastasis status and therapy assessment in oligo-metastasis prostate cancer;Frontiers in Oncology;2022-08-26

4. Postoperative moderately hypofractionated radiotherapy in prostate cancer: a mono-institutional propensity-score-matching analysis between adjuvant and early-salvage radiotherapy;La radiologia medica;2022-03-26

5. PSMA-guided metastases directed therapy for bone castration sensitive oligometastatic prostate cancer: a multi-institutional study;Clinical & Experimental Metastasis;2022-03-09